Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
86.70    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.578%)
Market Cap: £364.45m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Directorate Change

10 Nov 2011 07:00

RNS Number : 8235R
PZ CUSSONS PLC
10 November 2011
 



 

PZ CUSSONS PLC

 

10 November 2011

Changes to the Board of Directors

Appointment of Non-executive Directors

 

PZ Cussons plc ("PZ Cussons" or the "Company") is pleased to announce the appointment to the Board of two Non-executive Directors.

 

Helen Owers and Ngozi Edozien will each join the Board as Non-executive Directors on 1 January 2012.

 

Helen Owers is Chief Development Officer for Thomson Reuters Professional, with responsibility for the company's expansion in Rapidly Developing Economies. She has previously held a number of operational roles within the Thomson Reuters group and played an important role in the development of the company's digital strategy. Most recently as President of Global Businesses for Thomson Reuters Legal, she built new businesses in a number of emerging markets, balancing local consumer insights and needs with the globalisation of the business and key products. Before joining Thomson Reuters, Helen worked as a consultant with Gemini Consulting, developing and implementing corporate and operational strategies for a number of consumer products clients.  

 

Ngozi Edozien is Chief Executive, West Africa at Actis, a leading private equity investor in emerging markets, where she is responsible for all aspects of the company's business in the region. Prior to joining Actis, Ngozi was VP Strategic Planning and Business Development for Pfizer Inc based in New York where she drove the financial and strategic planning processes of the company in addition to leading strategy projects and transactions for Pfizer. She was transferred to Nigeria in 2005 to run Pfizer's businesses in East, West and Central Africa, before being appointed in 2008 as Chief Executive of the Equity Vehicle for Health in Africa, an investment company focused on investing in private healthcare businesses in the continent. Ngozi has a background in strategic consulting, having spent seven years with McKinsey & Co, working principally in the consumer products and healthcare sectors. A US/Nigerian citizen, Ngozi was educated in the United States at Harvard University and started her career in corporate finance at JP Morgan.

 

Derek Lewis, who was appointed to the Board as a Non-executive Director in 2004 and has served as Senior Independent Director since 2008, will retire from the Board at the Company's next AGM in September 2012.

 

Richard Harvey, Chairman of PZ Cussons, said:

'We are delighted to welcome Helen and Ngozi to the Board. They each bring with them a wealth of relevant experience and insights which will be very valuable as we continue to grow the business. Their appointments will also serve to make the Board more representative of the Group's geographic profile and its customer base and reflect our belief in the benefits of diversity - in the Boardroom and across the whole of the Group."

"Although Derek will be remaining on the Board until next September, I would also like at this opportunity to thank him for his significant contribution to the Board and to the PZ Cussons Group since his appointment seven years ago, during which time PZ Cussons has delivered significant growth in shareholder value."

 

- Ends -

 

Notes: Ngozi Edozien is a Non-executive Director of Diamond Bank Plc, a company listed on the Nigerian Stock Exchange. There is no other information in relation to either appointment which is required to be disclosed by paragraph 9.6.13 of the Listing Rules.

 

For further information please contact:

 

PZ Cussons Plc Tel: 0161 435 1000

Brandon Leigh, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

John Olsen / James White

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADKCDQOBDDFDK
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.